Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-31 @ 11:06 AM
Study NCT ID:
NCT00790894
Status:
TERMINATED
Last Update Posted:
2011-05-18
First Post:
2008-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)
Sponsor:
Hellenic Cooperative Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-13
First Submit QC Date:
None
Study First Post Date:
2008-11-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-17
Last Update Post Date:
2011-05-18
Last Update Post Date Type:
ESTIMATED